131 related articles for article (PubMed ID: 3114751)
41. Prevention of recurrent diabetes in syngenic islet-transplanted NOD mice by transfusion of autoreactive T lymphocytes.
Utsugi T; Nagata M; Kawamura T; Yoon JW
Transplantation; 1994 Jun; 57(12):1799-804. PubMed ID: 7912459
[TBL] [Abstract][Full Text] [Related]
42. Reversal of beta-cell suppression in vitro in pancreatic islets isolated from nonobese diabetic mice during the phase preceding insulin-dependent diabetes mellitus.
Strandell E; Eizirik DL; Sandler S
J Clin Invest; 1990 Jun; 85(6):1944-50. PubMed ID: 2189896
[TBL] [Abstract][Full Text] [Related]
43. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
[TBL] [Abstract][Full Text] [Related]
44. Adult bone marrow-derived cells trans-differentiating into insulin-producing cells for the treatment of type I diabetes.
Oh SH; Muzzonigro TM; Bae SH; LaPlante JM; Hatch HM; Petersen BE
Lab Invest; 2004 May; 84(5):607-17. PubMed ID: 15034596
[TBL] [Abstract][Full Text] [Related]
45. Co-microencapsulation of BMSCs and mouse pancreatic β cells for improving the efficacy of type I diabetes therapy.
Long R; Liu Y; Wang S; Ye L; He P
Int J Artif Organs; 2017 May; 40(4):169-175. PubMed ID: 28362046
[TBL] [Abstract][Full Text] [Related]
46. Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice.
Shapiro AM; Suarez-Pinzon WL; Power R; Rabinovitch A
Diabetologia; 2002 Feb; 45(2):224-30. PubMed ID: 11935154
[TBL] [Abstract][Full Text] [Related]
47. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E.
Hancock WW; Polanski M; Zhang J; Blogg N; Weiner HL
Am J Pathol; 1995 Nov; 147(5):1193-9. PubMed ID: 7485382
[TBL] [Abstract][Full Text] [Related]
48. The anti-inflammatory compound lisofylline prevents Type I diabetes in non-obese diabetic mice.
Yang ZD; Chen M; Wu R; McDuffie M; Nadler JL
Diabetologia; 2002 Sep; 45(9):1307-14. PubMed ID: 12242464
[TBL] [Abstract][Full Text] [Related]
49. Transplantation of islet-like cell clusters derived from human dental pulp stem cells restores normoglycemia in diabetic mice.
Kanafi MM; Rajeshwari YB; Gupta S; Dadheech N; Nair PD; Gupta PK; Bhonde RR
Cytotherapy; 2013 Oct; 15(10):1228-36. PubMed ID: 23845187
[TBL] [Abstract][Full Text] [Related]
50. Bone marrow transplantation as a strategy for treatment of non-insulin-dependent diabetes mellitus in KK-Ay mice.
Than S; Ishida H; Inaba M; Fukuba Y; Seino Y; Adachi M; Imura H; Ikehara S
J Exp Med; 1992 Oct; 176(4):1233-8. PubMed ID: 1402665
[TBL] [Abstract][Full Text] [Related]
51. Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells.
Ikehara S; Kawamura M; Takao F; Inaba M; Yasumizu R; Than S; Hisha H; Sugiura K; Koide Y; Yoshida TO
Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8341-4. PubMed ID: 2236044
[TBL] [Abstract][Full Text] [Related]
52. Remission of type 1 diabetes after anti-CD3 antibody treatment and transplantation of embryonic pancreatic precursors.
Begum S; Chen W; Herold KC; Papaioannou VE
Endocrinology; 2009 Oct; 150(10):4512-20. PubMed ID: 19589867
[TBL] [Abstract][Full Text] [Related]
53. Treatment of streptozotocin-induced diabetes mellitus in mice by intra-bone marrow bone marrow transplantation plus portal vein injection of beta cells induced from bone marrow cells.
Li M; Inaba M; Guo KQ; Hisha H; Abraham NG; Ikehara S
Int J Hematol; 2007 Dec; 86(5):438-45. PubMed ID: 18192113
[TBL] [Abstract][Full Text] [Related]
54. Chimerism-induced remission of overt diabetes in nonobese diabetic mice.
Li H; Inverardi L; Ricordi C
Transplant Proc; 1999; 31(1-2):640. PubMed ID: 10083274
[No Abstract] [Full Text] [Related]
55. Experimental models of type-I diabetes.
Bach JF; Boitard C
Pathol Immunopathol Res; 1986; 5(3-5):384-415. PubMed ID: 3110756
[No Abstract] [Full Text] [Related]
56. Lessons from the NOD mouse for the pathogenesis and immunotherapy of human type 1 (insulin-dependent) diabetes mellitus.
Lampeter EF; Signore A; Gale EA; Pozzilli P
Diabetologia; 1989 Oct; 32(10):703-8. PubMed ID: 2687059
[TBL] [Abstract][Full Text] [Related]
57. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion.
Ianus A; Holz GG; Theise ND; Hussain MA
J Clin Invest; 2003 Mar; 111(6):843-50. PubMed ID: 12639990
[TBL] [Abstract][Full Text] [Related]
58. Recovery from overt type 1 diabetes ensues when immune tolerance and β-cell formation are coupled with regeneration of endothelial cells in the pancreatic islets.
Wan X; Guloglu FB; Vanmorlan AM; Rowland LM; Zaghouani S; Cascio JA; Dhakal M; Hoeman CM; Zaghouani H
Diabetes; 2013 Aug; 62(8):2879-89. PubMed ID: 23715620
[TBL] [Abstract][Full Text] [Related]
59. Autoimmune polyendocrine failure--type 1 (insulin-dependent) diabetes mellitus and hypothyroidism--after allogeneic bone marrow transplantation in a patient with lymphoblastic leukaemia.
Vialettes B; Maraninchi D; San Marco MP; Birg F; Stoppa AM; Mattei-Zevaco C; Thivolet C; Hermitte L; Vague P; Mercier P
Diabetologia; 1993 Jun; 36(6):541-6. PubMed ID: 8101499
[TBL] [Abstract][Full Text] [Related]
60. [Cure of type 1 diabetes mellitus. Is it a reachable goal?].
Goñi MJ
An Sist Sanit Navar; 2008; 31(3):215-8. PubMed ID: 19165287
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
